AcuityMD develops a medical technology software platform for commercializing and improving medical devices with data.
AcuityMD develops a medical technology software platform for commercializing and improving medical devices with data.
Enterprise Systems (Healthcare)📍 Boston, MAFounded 2018
Current Valuation
$980M
as of 2025-Q4
PRIVATE
QL Price
$746.4M
-25% vs last round
QuantLogix's current estimate for AcuityMD, published 2026-09-27 — below the last disclosed round of $1.0B (2026-04).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.0B
2026-04
weight 0.71
Secondary market print
$433M
2026-06-27
weight 0.58
How this price has held up
No round has priced for AcuityMD since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, AcuityMD, 2026-09-27 (b28ed884730a2b79).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is AcuityMD going public?
No. AcuityMD is private and has not filed to go public. There is no S-1 on file.
What is AcuityMD's valuation in 2026?
AcuityMD is valued at $980M as of 2025-Q4, set by its Series C ($90M, Dec 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has AcuityMD filed an S-1?
No public S-1 is on file for AcuityMD.
How much has AcuityMD raised?
AcuityMD has raised $173.67M in total, most recently a Series C of $90M in Dec 2025.
Is AcuityMD publicly traded — can you buy AcuityMD stock?
No. AcuityMD is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for AcuityMD on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2018
HQ
Boston, MA
Employees
254
Total Raised
$173.67M
Last Round
Series C — $90M (Dec 2025)
IPO Status
private
Fundraising Status
Series C · $90M · 9 mo ago
privateTotal raised $173.67M
Secondary Market
Implied price / share
$3.89
Last round price / share
$8.99
vs last round
-56.7%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$90M
Dec 2025
—
$980M
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
9
via greenhouse
Product-build share
56%
engineering, research, product, design
Trajectory
steady
product-led hiring — 56% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Principal Medtech Architect Program Manager Senior Product Manager Senior Software Engineer, ApplicationsSenior Software Engineer, Infrastructure Enterprise Account Executive
Counted from AcuityMD's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q4. Refreshed quarterly.